Which set of symptoms most strongly indicates possible heart failure in a patient exposed to anthracyclines?

Prepare for the OPSA Essentials Test. Study with flashcards, multiple choice questions, hints, and explanations for every question. Get exam-ready now!

Multiple Choice

Which set of symptoms most strongly indicates possible heart failure in a patient exposed to anthracyclines?

Explanation:
Heart failure from anthracycline exposure shows fluid overload and reduced pumping ability. The strongest clue among these symptoms is shortness of breath at rest together with ankle swelling and rapid weight gain, which together reflect the body’s inability to manage fluid and maintain circulation. Ankle edema indicates venous congestion, rapid weight gain flags fluid retention, and dyspnea at rest suggests a significantly reduced cardiac output. Chest pain at rest is more indicative of ischemia rather than heart failure, shortness of breath only with exertion can occur with other conditions, and palpitations point to possible arrhythmias but do not by themselves signify heart failure. In this context, the combination of resting dyspnea, edema, and rapid weight gain most strongly signals possible cardiomyopathy from anthracyclines and warrants prompt evaluation and management.

Heart failure from anthracycline exposure shows fluid overload and reduced pumping ability. The strongest clue among these symptoms is shortness of breath at rest together with ankle swelling and rapid weight gain, which together reflect the body’s inability to manage fluid and maintain circulation. Ankle edema indicates venous congestion, rapid weight gain flags fluid retention, and dyspnea at rest suggests a significantly reduced cardiac output. Chest pain at rest is more indicative of ischemia rather than heart failure, shortness of breath only with exertion can occur with other conditions, and palpitations point to possible arrhythmias but do not by themselves signify heart failure. In this context, the combination of resting dyspnea, edema, and rapid weight gain most strongly signals possible cardiomyopathy from anthracyclines and warrants prompt evaluation and management.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy